HX
Income statement / Annual
Last year (2024), Akso Health Group's total revenue was $2.41 M,
a decrease of 81.68% from the previous year.
In 2024, Akso Health Group's net income was -$9.46 M.
See Akso Health Group,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
| Operating Revenue |
$2.41 M |
$13.18 M |
$6.00 M |
$1.75 M |
$6.91 M |
$3.70 M |
$107.26 M |
$22.92 M |
$11.89 M |
$4.65 M |
| Cost of Revenue |
$2.29 M
|
$11.91 M
|
$5.39 M
|
$544.57 K
|
$0.00
|
$0.00
|
$8.50 M
|
$5.15 M
|
$2.36 M
|
$1.61 M
|
| Gross Profit |
$122.13 K
|
$1.27 M
|
$605.13 K
|
$1.21 M
|
$6.91 M
|
$3.70 M
|
$98.76 M
|
$17.77 M
|
$9.54 M
|
$3.04 M
|
| Gross Profit Ratio |
0.05
|
0.1
|
0.1
|
0.69
|
1
|
1
|
0.92
|
0.78
|
0.8
|
0.65
|
| Research and Development Expenses |
$0.00
|
-$0.99
|
$421.19 K
|
$544.57 K
|
$1.03 M
|
$0.00
|
$2.82 M
|
$1.57 M
|
$895.99 K
|
$1.61 M
|
| General & Administrative Expenses |
$8.59 M
|
$15.53 M
|
$2.67 M
|
$2.03 M
|
$26.80 M
|
$3.13 M
|
$7.64 M
|
$2.65 M
|
$1.55 M
|
$733.92 K
|
| Selling & Marketing Expenses |
$168.42 K
|
$6.66 K
|
$240.93 K
|
$55.47 K
|
$1.46 M
|
$1.17 M
|
$15.24 M
|
$5.21 M
|
$3.84 M
|
$2.61 M
|
| Selling, General & Administrative Expenses |
$8.76 M
|
$15.54 M
|
$15.63 M
|
$28.36 M
|
$43.27 M
|
$48.84 M
|
$22.89 M
|
$7.86 M
|
$5.39 M
|
$3.34 M
|
| Other Expenses |
$0.00
|
$1.20 M
|
-$780.55 K
|
-$164.92 K
|
$1.60 M
|
$2.31 M
|
$660.88 K
|
$179.53 K
|
$26.27 K
|
-$7.70 K
|
| Operating Expenses |
$8.76 M
|
$15.54 M
|
$16.05 M
|
$28.36 M
|
$43.27 M
|
$48.84 M
|
$22.89 M
|
$7.86 M
|
$5.39 M
|
$3.34 M
|
| Cost And Expenses |
$11.05 M
|
$27.45 M
|
$21.44 M
|
$28.90 M
|
$48.26 M
|
$56.23 M
|
$31.38 M
|
$13.01 M
|
$7.75 M
|
$4.94 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$590.12 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$804.14 K
|
$2.15 M
|
$2.51 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$138.24 K
|
$18.39 K
|
$18.39 K
|
$15.16 K
|
$120.52 K
|
$406.80 K
|
$174.38 K
|
$92.22 K
|
$61.39 K
|
$19.70 K
|
| EBITDA |
$0.00 |
-$14.25 M |
-$2.44 M |
-$2.07 M |
-$16.30 M |
-$7.17 M |
$76.05 M |
$10.01 M |
$4.20 M |
-$278.92 K |
| EBITDA Ratio |
0
|
-1.08
|
-0.41
|
-1.18
|
-2.36
|
-1.94
|
0.71
|
0.44
|
0.35
|
-0.06
|
| Operating Income Ratio |
-3.58
|
-1.08
|
-2.52
|
-15.47
|
-5.33
|
1.38
|
0.71
|
0.43
|
0.35
|
-0.06
|
| Total Other Income/Expenses Net |
-$453.75 K
|
$1.20 M
|
-$747.82 K
|
-$3.92 M
|
$1.23 M
|
$381.15 K
|
$660.88 K
|
$179.53 K
|
$26.27 K
|
-$7.70 K
|
| Income Before Tax |
-$9.09 M
|
-$13.07 M
|
-$16.72 M
|
-$31.07 M
|
-$66.93 M
|
$7.41 M
|
$76.54 M
|
$10.09 M
|
$4.17 M
|
-$306.33 K
|
| Income Before Tax Ratio |
-3.77
|
-0.99
|
-2.79
|
-17.7
|
-9.68
|
2
|
0.71
|
0.44
|
0.35
|
-0.07
|
| Income Tax Expense |
$24.99 K
|
$17.55 K
|
$131.43 K
|
$482.98 K
|
$4.27 M
|
$1.87 M
|
$11.03 M
|
$1.52 M
|
$628.25 K
|
$43.84 K
|
| Net Income |
-$9.46 M
|
-$13.08 M
|
-$16.85 M
|
-$31.55 M
|
-$71.20 M
|
$5.53 M
|
$65.48 M
|
$8.57 M
|
$3.54 M
|
-$350.17 K
|
| Net Income Ratio |
-3.92
|
-0.99
|
-2.81
|
-17.98
|
-10.3
|
1.5
|
0.61
|
0.37
|
0.3
|
-0.08
|
| EPS |
-0.21 |
-0.57 |
-0.85 |
-1.94 |
-4.38 |
0.31 |
4.12 |
0.54 |
0.22 |
-0.0219 |
| EPS Diluted |
-0.2 |
-0.57 |
-0.85 |
-1.94 |
-4.38 |
0.31 |
4.12 |
0.54 |
0.22 |
-0.0219 |
| Weighted Average Shares Out |
$45.04 M
|
$22.87 M
|
$19.87 M
|
$16.28 M
|
$16.25 M
|
$17.64 M
|
$15.89 M
|
$15.97 M
|
$15.97 M
|
$15.97 M
|
| Weighted Average Shares Out Diluted |
$47.17 M
|
$22.87 M
|
$19.87 M
|
$16.28 M
|
$16.25 M
|
$17.64 M
|
$15.89 M
|
$15.97 M
|
$15.97 M
|
$15.97 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
